Author

Yulia V. Sveshnikova

Observed names: Y.V. Sveshnikova, Yulia Sveshnikova, Yuliya Sveshnikova

Institution: Regional Children's Clinical Hospital No. 1

Observed institutions: Vall d'Hebron Hospital Universitari, Regional Children's Clinical Hospital No. 1

ORCID: 0000-0001-6371-6792

Observed ORCID: 0000-0001-6371-6792

OpenAlex ID: A5109505418

Clinical Outcomes in Patients With COVID-19 and Hematologic Disease

2023 · Olga A. Aleshina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia · 9

COVID-19 and hematologic diseases: Risk factors and long-term follow-up of CHRONOS19 Registry.

2021 · Kristina Zakurdaeva, Olga A. Gavrilina, et al. · Journal of Clinical Oncology · 4

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia

2021 · Olga A. Gavrilina, Kristina A. Zakurdaeva, et al. · Blood · 1

ALL-329 Ph-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescent and Young Adults: Long-Term Outcomes After Treatment According to the Adult Strategy RALL Protocol

2023 · Olga Aleshina, Ekaterina Kotova, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: ALL-329 Ph-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescent and Young Adults: Long-Term Outcomes After Treatment According to the Adult Strategy RALL Protocol

2023 · Olga Aleshina, Ekaterina Kotova, et al. · Clinical Lymphoma Myeloma & Leukemia

P396: Fifteen Years of Russian Research in the Treatment of Adult Patients With Acute Ph-negative Lymphoblastic Leukemia According to the Protocols All-2009 and All-2016.

2023 · Olga Aleshina (Gavrilina), Vera Troitskaya, et al. · HemaSphere

Pb1866: Is Allo-hsct in Cr1 Necessary for Aml Patients With Mrd Negativity Achieved After the First Induction Course? Russian Prospective Multicenter Randomized Trial in Aml Patients Under the Age of 60

2023 · Elena Parovichnikova, Irina Lukianova, et al. · HemaSphere

1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies

2021 · K. Zakurdaeva, O.A. Gavrilina, et al. · Annals of Oncology

ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry

2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia

Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry

2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 10

Citation count: 14

H-index: 2

I10-index: